• Explore /
  • Poster
  • / Phase Ib (COSMIC-021) trial of cabozantinib (C) in urothelial carcinoma (UC) or C in combination with atezolizumab (A) in patients (pts) with UC, castrate resistant prostate cancer (CRPC) or renal cell carcinoma (RCC).

Phase Ib (COSMIC-021) trial of cabozantinib (C) in urothelial carcinoma (UC) or C in combination with atezolizumab (A) in patients (pts) with UC, castrate resistant prostate cancer (CRPC) or renal cell carcinoma (RCC).

Abstract Poster

Authors

Sumanta Pal

Sumanta K. Pal

City of Hope, Duarte, CA

Sumanta K. Pal , Ulka N. Vaishampayan , Daniel E. Castellano , Andrea Necchi , Carla M.L.- Van Herpen , Giridharan Ramsingh , Yohann Loriot , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Clinical Trial Registration Number

NCT03170960

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr TPS683)

DOI

10.1200/JCO.2019.37.7_suppl.TPS683

Abstract #

TPS683

Poster Bd #

K14

Abstract Disclosures

Similar Posters

First Author: Neeraj Agarwal

First Author: Neeraj Agarwal

First Author: Melissa Andrea Reimers

First Author: Toni K. Choueiri